These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28624842)
1. Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson's Disease Patients: Search for a Disease Indicator. Yang L; Guo C; Zhu J; Feng Y; Chen W; Feng Z; Wang D; Sun S; Lin W; Wang Y Med Sci Monit; 2017 Jun; 23():2972-2978. PubMed ID: 28624842 [TBL] [Abstract][Full Text] [Related]
2. Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients. Chen S; Liu Y; Niu Y; Xu Y; Zhou Q; Xu X; Wang J; Yu M Neurosci Lett; 2017 May; 648():21-25. PubMed ID: 28359932 [TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients. Kustrimovic N; Comi C; Magistrelli L; Rasini E; Legnaro M; Bombelli R; Aleksic I; Blandini F; Minafra B; Riboldazzi G; Sturchio A; Mauri M; Bono G; Marino F; Cosentino M J Neuroinflammation; 2018 Jul; 15(1):205. PubMed ID: 30001736 [TBL] [Abstract][Full Text] [Related]
4. Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease. Chen Y; Qi B; Xu W; Ma B; Li L; Chen Q; Qian W; Liu X; Qu H Mol Med Rep; 2015 Oct; 12(4):6105-11. PubMed ID: 26239429 [TBL] [Abstract][Full Text] [Related]
5. Inflammation in Parkinson's disease. Tufekci KU; Meuwissen R; Genc S; Genc K Adv Protein Chem Struct Biol; 2012; 88():69-132. PubMed ID: 22814707 [TBL] [Abstract][Full Text] [Related]
6. Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies. Rocha NP; de Miranda AS; Teixeira AL Biomed Res Int; 2015; 2015():628192. PubMed ID: 26295044 [TBL] [Abstract][Full Text] [Related]
7. Th17 cells: a promising therapeutic target for Parkinson's disease? Prots I; Winner B Expert Opin Ther Targets; 2019 Apr; 23(4):309-314. PubMed ID: 30871383 [TBL] [Abstract][Full Text] [Related]
8. The role of Th17 cells in auto-inflammatory neurological disorders. Tahmasebinia F; Pourgholaminejad A Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):408-416. PubMed ID: 28760387 [TBL] [Abstract][Full Text] [Related]
9. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS. Salem ML; Zidan AA; Attia M; El-Naggar RE; Nassef M; Abou El-Azm AR; El-Bate H; Yussif M; Galal S; Abo Senna M; El Demellawy M Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):188-198. PubMed ID: 28472907 [TBL] [Abstract][Full Text] [Related]
10. IFN-γ decreased the suppressive function of CD33 Zhan X; Hu S; Wu Y; Li M; Liu T; Ming S; Wu M; Liu M; Huang X Mol Immunol; 2018 Feb; 94():107-120. PubMed ID: 29291452 [TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs. Ji J; Xu J; Zhao S; Liu F; Qi J; Song Y; Ren J; Wang T; Dou H; Hou Y Clin Sci (Lond); 2016 Aug; 130(16):1453-67. PubMed ID: 27231253 [TBL] [Abstract][Full Text] [Related]
12. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice. Manocha GD; Floden AM; Puig KL; Nagamoto-Combs K; Scherzer CR; Combs CK Mol Neurodegener; 2017 Feb; 12(1):17. PubMed ID: 28196514 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770 [TBL] [Abstract][Full Text] [Related]
15. Parkinson disease-associated Park J; Lee JW; Cooper SC; Broxmeyer HE; Cannon JR; Kim CH J Leukoc Biol; 2017 Oct; 102(4):1093-1102. PubMed ID: 28751472 [TBL] [Abstract][Full Text] [Related]
16. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping. An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966 [TBL] [Abstract][Full Text] [Related]
17. Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis. Jiao Z; Hua S; Wang W; Wang H; Gao J; Wang X Scand J Rheumatol; 2013; 42(2):85-90. PubMed ID: 23126644 [TBL] [Abstract][Full Text] [Related]
18. Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease. Sommer A; Marxreiter F; Krach F; Fadler T; Grosch J; Maroni M; Graef D; Eberhardt E; Riemenschneider MJ; Yeo GW; Kohl Z; Xiang W; Gage FH; Winkler J; Prots I; Winner B Cell Stem Cell; 2018 Jul; 23(1):123-131.e6. PubMed ID: 29979986 [TBL] [Abstract][Full Text] [Related]
19. Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson's Disease. Liu Z; Huang Y; Cao BB; Qiu YH; Peng YP Mol Neurobiol; 2017 Dec; 54(10):7762-7776. PubMed ID: 27844285 [TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease. Kaur K; Gill JS; Bansal PK; Deshmukh R J Neurol Sci; 2017 Oct; 381():308-314. PubMed ID: 28991704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]